Anne Hudson Blaes, MD, on Aromatase Inhibitors and Cardiovascular Disease

2016 San Antonio Breast Cancer Symposium
Tweet this page

Anne Hudson Blaes, MD, of the University of Minnesota, discusses the association between aromatase inhibitors, endothelial function, and early heart disease (Abstract S5-07).

Advertisement

Advertisement



;
Advertisement

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.